Cardiac Specific Overexpression of Transglutaminase II (Gh) Results in a Unique Hypertrophy Phenotype Independent of Phospholipase C Activation
Open Access
- 1 July 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (30) , 21291-21296
- https://doi.org/10.1074/jbc.274.30.21291
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Phospholipase C-δ1 and oxytocin receptor signalling: evidence of its role as an effectorBiochemical Journal, 1998
- α1-Adrenergic Receptor Signaling via Gh Is Subtype Specific and Independent of Its Transglutaminase ActivityJournal of Biological Chemistry, 1996
- Evidence That Phospholipase δ1 Is the Effector in the Gh (Transglutaminase II)-mediated SignalingPublished by Elsevier ,1996
- Expression of tissue‐type transglutaminase correlates positively with metastatic properties of human melanoma cell linesInternational Journal of Cancer, 1995
- G h : a GTP-Binding Protein with Transglutaminase Activity and Receptor Signaling FunctionScience, 1994
- Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.The Journal of cell biology, 1993
- Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissuesThe FASEB Journal, 1991
- GTP hydrolysis by guinea pig liver transglutaminaseBiochemical and Biophysical Research Communications, 1989
- Increase in proliferative markers after inhibition of transglutaminase.Proceedings of the National Academy of Sciences, 1981
- The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of TransglutaminasesAdvances in Protein Chemistry, 1977